Passage BIO, Inc.
Biotechnology company · Philadelphia, Pennsylvania, United States · Nasdaq: PASG
Passage BIO, Inc. is a biotechnology company headquartered in Philadelphia, Pennsylvania, United States. Its earliest recorded incorporation is in 2017. Its shares trade on Nasdaq under the ticker PASG. It has reported private securities offerings to the US SEC, most recently $110 million sold in a notice filed in 2019.
Passage BIO at a glance
What does Passage BIO do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $110 million sold (2019).
Frequently asked questions about Passage BIO
Where is Passage BIO headquartered?
Passage BIO, Inc. is headquartered in Philadelphia, Pennsylvania, United States.
What does Passage BIO do?
Passage BIO, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Passage BIO a public company?
Yes. Passage BIO, Inc. trades on Nasdaq under the ticker PASG.
When was Passage BIO founded?
The earliest incorporation on record for Passage BIO, Inc. is in 2017, according to public company registers.
Similar companies
- Spark Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- Cabaletta Bio, Inc.Philadelphia, Pennsylvania, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.